Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|---|
| 126 |
126
Instil Bio
TIL
$41.8M
| – | – | – | – |
|
| 127 |
127
Tenaya Therapeutics
TNYA
$92M
| – | – | – | – |
|
| 128 |
128
DELISTED
Turnstone Biologics
TSBX
| – | – | – | – |
|
| 129 |
129
Taysha Gene Therapies
TSHA
$1.22B
| – | – | – | – |
|
| 130 |
130
DELISTED
2seventy bio
TSVT
| – | – | – | – |
|
| 131 |
131
Voyager Therapeutics
VYGR
$126M
| – | – | – | – |
|